Publication: Neutrophil-to-lymphocyte ratio predicts PSA response, but not outcomes in patients with castration-resistant prostate cancer treated with docetaxel
Loading...
Program
relationships.isAuthorOf
Author
Sumbul, Ahmet Taner
ÖZYILKAN, ÖZGÜR
Sezer, Ahmet
Abali, Huseyin
Kose, Fatih
Gultepe, Ilhami
Mertsoylu, Huseyin
Muallaoglu, Sadik
Advisor
Language
Type
Publisher
Journal Title
Journal ISSN
Volume Title
Abstract
The neutrophil-to-lymphocyte ratio (NLR) is a marker of systemic inflammatory response and evidences for the relationship between NLR and the response to treatment gradually increases in cancer patients. In this study, we aimed to investigate the effect of the pretreatment NLR and other factors related to the patient on predicting the outcome of docetaxel + prednisone chemotherapy in prostate cancer patients who become castration resistant.
Description
Source
Keywords
Keywords
Citation
Sumbul A. T. , Sezer A., Abali H., Kose F., Gultepe I., Mertsoylu H., Muallaoglu S., ÖZYILKAN Ö., -Neutrophil-to-lymphocyte ratio predicts PSA response, but not outcomes in patients with castration-resistant prostate cancer treated with docetaxel-, INTERNATIONAL UROLOGY AND NEPHROLOGY, cilt.46, ss.1531-1535, 2014